Chemycal has been acquired by 3E

Learn More

SCCS - Minutes of the 15th plenary meeting, Luxembourg, 30-31 March 2021


Your substances

None

This news contains references also to other Substances


The Minutes of the SCCS 15th plenary meeting includes the following items:

New mandate(s)

(*) Four new mandates for endocrine disrupting (ED) substances from Group A (4-Methylbenzylidene camphor/4-MBC, Butylated Hydroxytoluene/ BHT, Kojic acid, Genistein and Daidzein)

(*) A new mandate for the revision of the Vitamin A Opinion

(*) SCHEER asked the SCCS for an additional representative in their new WG on TiO2 in toys. The SCCS agreed.

Draft opinions

(*) Nanomaterials in cosmetic ingredients

(*) Hydroxyapatite (nano) – submission II

(*) Gold (nano) -Colloidal Gold (nano) [, Gold Thioethylamino Hyaluronic Acid (nano) and Acetyl heptapeptide-9, Colloidal gold (nano)

(*) Platinum (nano)

(*) Colloidal Platinum (nano) 

(*) Acetyl tetrapeptide-17

(*) Colloidal Platinum (nano)

Cosmetic Ingredients (*) Methyl salicylate (methyl 2-hydroxybenzoate). Tasks have been allocated to the members and a revised version of the draft preliminary Opinion will be discussed at the next April WG meeting.

(*) C054 hair dye. The Applicant sent additional study to the SCCS that is still under assessment. Tasks have been allocated to the members and a revised version of the draft preliminary Opinion will be discussed at the next April WG meeting.

(*) Prostaglandin and analogues. Relevant data are lacking. A draft preliminary Opinion will be discussed at the next WG meeting.

(*) Formadehyde releasers. A first draft of the preliminary Advice will be prepared for discussion at the next April WG meeting.

Comments on opinions

(*) BPA in clothing The following final Opinions have been adopted and will published on the website: SCCS - Opinions 2016 - 2021 | Public Health (europa.eu)

(*) Resorcinol

(*) Propylparaben

(*) Octocrylene

(*) Benzophenone-3 6. Addendum to the scientific Opinion SCCS/1613/19 on the safety of aluminium in cosmetic products - Submission II

(*) Homosalate: the Applicant sent additional studies to the SCCS that are still under assessment. Tasks have been allocated to the members and a revised version of the final Opinion will be discussed at the next WG meeting.

CONTINUE READING ON ec.europa.eu

                   

Related News

Loading...